GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » Price-to-Tangible-Book

Telix Pharmaceuticals (Telix Pharmaceuticals) Price-to-Tangible-Book : 125.93 (As of May. 13, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-13), Telix Pharmaceuticals's share price is $10.20. Telix Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.08. Hence, Telix Pharmaceuticals's Price to Tangible Book Ratio of today is 125.93.

The historical rank and industry rank for Telix Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

TLPPF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.56   Med: 33.6   Max: 128.02
Current: 127.5

During the past 9 years, Telix Pharmaceuticals's highest Price to Tangible Book Ratio was 128.02. The lowest was 2.56. And the median was 33.60.

TLPPF's Price-to-Tangible-Book is ranked worse than
99.67% of 1221 companies
in the Biotechnology industry
Industry Median: 2.7 vs TLPPF: 127.50

A closely related ratio is called PB Ratio. As of today, Telix Pharmaceuticals's share price is $10.20. Telix Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.31. Hence, Telix Pharmaceuticals's P/B Ratio of today is 33.12.


Telix Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Telix Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Price-to-Tangible-Book Chart

Telix Pharmaceuticals Annual Data
Trend Sep99 Sep00 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 13.42 56.60 - 104.89 84.88

Telix Pharmaceuticals Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 26.92 104.89 210.56 84.88

Competitive Comparison of Telix Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Telix Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telix Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telix Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Telix Pharmaceuticals's Price-to-Tangible-Book falls into.



Telix Pharmaceuticals Price-to-Tangible-Book Calculation

Telix Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=10.20/0.081
=125.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Telix Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.